Psoriasis.
D000287:Administration, Topical; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000963:Antimetabolites / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D006965:Hyperplasia / Q000473:pathology; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007642:Keratosis / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D011602:Psychophysiologic Disorders / Q000209:etiology; D013638:Tars / Q000627:therapeutic use; D014467:Ultraviolet Therapy
D000305:Adrenal Cortex Hormones; D000963:Antimetabolites; D013638:Tars; D006918:Hydroxyurea; D008727:Methotrexate